Literature DB >> 26895195

Single Breath-Hold T1ρ-Mapping of the Heart for Endogenous Assessment of Myocardial Fibrosis.

Joep W M van Oorschot1, Fredy Visser, Anouk L M Eikendal, Evert-Jan P A Vonken, Peter R Luijten, Steven A J Chamuleau, Tim Leiner, Jaco J M Zwanenburg.   

Abstract

OBJECTIVES: In this study, we propose a method to acquire high spatial-resolution T1ρ-maps, which allows bright and black-blood imaging, in a single breath-hold. To validate this innovative method, the reproducibility was tested in phantoms and volunteers. Lastly, the sensitivity and specificity for infarct detection was compared with the criterion standard late gadolinium enhancement (LGE).
METHODS: T1ρ-mapping was performed using a T1ρ-prepared balanced steady-state free precession sequence at 1.5 T and 3 T. Five images with increasing spin-lock preparation times (spin-lock = 0, 10, 20, 30, 40 milliseconds, amplitude = 500 Hz) were acquired with an interval of 3 beats. Black-blood imaging was performed using a double inversion pulse sequence. The method was tested in 2 times 10 healthy volunteers at 1.5 and 3 T and in 9 myocardial infarction patients at 1.5 T. T1ρ-maps, and LGE images were scored for presence and extent of myocardial scarring.
RESULTS: Phantom results show that the proposed T1ρ-mapping method gives accurate T1ρ-values. The mean T1ρ-relaxation time of the myocardium in healthy controls was 52.8 ± 1.8 milliseconds at 1.5 T and 46.4 ± 1.8 milliseconds at 3 T. In patients, the T1ρ of infarcted myocardium was (82.4 ± 5.2 milliseconds), and the T1ρ of remote myocardium was (54.2 ± 2.8 milliseconds; P < 0.0001). Sensitivity of infarct detection on a T1ρ-map was 70%, with a specificity of 94%, compared with LGE.
CONCLUSIONS: In this study, we have investigated a method to acquire high spatial-resolution T1ρ-maps of the heart in a single breath-hold. This method proved to be reproducible and had high specificity compared with LGE and can thus be used for the endogenous detection of myocardial fibrosis in patients with ischemic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895195     DOI: 10.1097/RLI.0000000000000261

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

Review 1.  Cardiovascular ultrashort echo time to map fibrosis-promises and challenges.

Authors:  Joanne D Schuijf; Bharath Ambale-Venkatesh; Yoshimori Kassai; Yoko Kato; Larry Kasuboski; Hideki Ota; Shelton D Caruthers; João Ac Lima
Journal:  Br J Radiol       Date:  2019-08-08       Impact factor: 3.039

2.  Simultaneous multislice imaging for native myocardial T1 mapping: Improved spatial coverage in a single breath-hold.

Authors:  Sebastian Weingärtner; Steen Moeller; Sebastian Schmitter; Edward Auerbach; Peter Kellman; Chetan Shenoy; Mehmet Akçakaya
Journal:  Magn Reson Med       Date:  2017-06-05       Impact factor: 4.668

3.  A non-contrast CMR index for assessing myocardial fibrosis.

Authors:  Qian Yin; Dana Abendschein; David Muccigrosso; Robert O'Connor; Thomas Goldstein; Ridong Chen; Jie Zheng
Journal:  Magn Reson Imaging       Date:  2017-04-28       Impact factor: 2.546

4.  Assessment of myocardial injury after reperfused infarction by T1ρ cardiovascular magnetic resonance.

Authors:  Rutger H Stoffers; Marie Madden; Mohammed Shahid; Francisco Contijoch; Joseph Solomon; James J Pilla; Joseph H Gorman; Robert C Gorman; Walter R T Witschey
Journal:  J Cardiovasc Magn Reson       Date:  2017-02-15       Impact factor: 5.364

5.  Accelerated free-breathing 3D T1ρ cardiovascular magnetic resonance using multicoil compressed sensing.

Authors:  Srikant Kamesh Iyer; Brianna Moon; Eileen Hwuang; Yuchi Han; Michael Solomon; Harold Litt; Walter R Witschey
Journal:  J Cardiovasc Magn Reson       Date:  2019-01-10       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.